In recent years, considerable progress has been made in unraveling the etio
logy of Alzheimer's disease (AD). Dominant mutations have been identified,
in the beta-amyloid precursor protein gene (APP), and in two homologous gen
es presenilin 1 (PSEN-1) and presenilin 2 (PSEN-2). The contribution of the
se mutations to the occurrence of AD in the general population is estimated
to be lower than 1p.100. A genetic risk factor of more importance on the p
opulation level is the Apolipoprotein E (APOE) gene that may explain up to
17p.100 of the prevalence of AD in the general population. It is clear that
other yet unknown genes must be involved in the etiology of AD. Two loci o
n chromosome 12 have been suggested, but no consistent effect could be foun
d, Important progress with regard to non-genetic risk factors concerns the
role of vascular and endocrine factors in the pathogenesis, Of major intere
st for the prevention of AD will be the interaction of genetic and non-gene
tic risk factors. Large scale, long term follow-up studies, ongoing at pres
ent, may clarify this issue.